50
Participants
Start Date
June 28, 2022
Primary Completion Date
September 1, 2025
Study Completion Date
September 1, 2026
Angiotensin II
Infusion of Angiotensin II initiated if participants require norepinephrine at a rate of \> 0.05 mcg/kg/min. The infusion will be titrated no more frequently than every 10 minutes during liver transplantation as a second line vasopressor and discontinued prior to leaving the operating room when the surgery is complete.
Saline
Infusion of 0.9% saline initiated if participants require norepinephrine at a rate of \> 0.05 mcg/kg/min. The infusion will be titrated no more frequently than every 10 minutes during liver transplantation as a second line vasopressor and discontinued prior to leaving the operating room when the surgery is complete.
RECRUITING
University of California, San Francisco, San Francisco
Collaborators (1)
La Jolla Pharmaceutical Company
INDUSTRY
University of California, San Francisco
OTHER